AMENDMENT TO CONVERTIBLE PROMISSORY NOTESConvertible Promissory Notes Amendment • May 10th, 2012 • Sandalwood Ventures • Metal mining
This Amendment to Convertible Promissory Notes (this “Agreement”) dated May 4, 2012, to be effective as of June 2, 2011 (the “Effective Date”), is by and among Sandalwood Ventures, Ltd. (the “Company”) and Cornerstone Global Investments (“Note Holder”), each a “Party” and collectively the “Parties.”
AMENDMENT NO. 2 TOConvertible Promissory Notes Amendment • December 21st, 2022 • Bubblr Inc. • Services-computer programming, data processing, etc. • Wyoming
AMENDMENT NO. 2 (this “Amendment”)December 15, 2022 to each of those certain Convertible Promissory Notes (collectively, the “Notes”) issued on November 5, 2021 pursuant to certain Note Purchase Agreements dated on or about November 5, 2021 (the “Note Purchase Agreements”), by and among Bubblr, Inc. (the “Company”) and Investors representing a Majority in Interest (the “Majority Investors”) and listed on the signature pages hereto dated as December 15, 2022. Capitalized terms not defined herein have the meanings set forth in the Note Purchase Agreements or the Notes, as applicable.
AMENDMENT OF THE MULTIPLE CONVERTIBLE PROMISSORY NOTESConvertible Promissory Notes Amendment • May 21st, 2018 • Lithium Exploration Group, Inc. • Metal mining
This Amendment to all of the Convertible Promissory Notes (the “Original Agreements”) entered into between Lithium Exploration Group Inc., (the “Seller”) and Concord Holding Group LLC (the “Buyer”) is hereby entered into on March 28, 2018.
SIXTH AMENDMENTConvertible Promissory Notes Amendment • January 17th, 2018 • Orbimed Advisors LLC • Biological products, (no disgnostic substances) • New York
This SIXTH AMENDMENT (this “Amendment”) is effective as of January 17, 2018 by XTANT MEDICAL HOLDINGS, INC., a Delaware corporation (the “Company”), ROS ACQUISITION OFFSHORE LP, a Cayman Islands Exempted Limited Partnership (“ROS”) and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (“Royalty Opportunities” and, together with ROS, collectively, the “Holders”).
SIXTH AMENDMENTConvertible Promissory Notes Amendment • January 23rd, 2018 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances) • New York
This SIXTH AMENDMENT (this “Amendment”) is effective as of January 17, 2018 by XTANT MEDICAL HOLDINGS, INC., a Delaware corporation (the “Company”), ROS acquisition offshore lp, a Cayman Islands Exempted Limited Partnership (“ROS”) and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (“Royalty Opportunities” and, together with ROS, collectively, the “Holders”).
OMNIBUS AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTESConvertible Promissory Notes Amendment • October 6th, 2011 • WaferGen Bio-Systems, Inc. • Laboratory analytical instruments • Nevada
THIS OMNIBUS AMENDMENT TO CONVERTIBLE PROMISSORY NOTES (this “Amendment”), dated as of September 30, 2011, by and among WAFERGEN BIO-SYSTEMS, INC., a Nevada corporation (the “Borrower”), and the other signatories hereto (such other signatories collectively, the “Holder Signatories,” and each, a “Holder Signatory”).
